Copyright
©2010 Baishideng.
World J Diabetes. May 15, 2010; 1(2): 57-64
Published online May 15, 2010. doi: 10.4239/wjd.v1.i2.57
Published online May 15, 2010. doi: 10.4239/wjd.v1.i2.57
Figure 1 Comparison of the two key elements of neurodegeneration (glial activation and apoptosis) between a representative case of diabetic patient without DR and a non-diabetic subject.
As can be seen, neurodegeneration is higher in the retina from the diabetic donor. A: Glial activation in the human retina. Glial fibrillar acidic protein (GFAP) immunofluorescence (green) from a non-diabetic donor (left panel) and a diabetic donor (right panel); B: Apoptosis in the human retina. Upper panel: Non-diabetic donor (B1: Propidium iodide, B2: TUNEL immunofluorescence). Low panel: Diabetic donor (B3: Propidium iodide, B4: TUNEL immunofluorescence). RPE: Retinal pigment epithelium; ONL: Outer nuclear layer; INL: Inner nuclear layer; GCL: Ganglion cell layer. The bar represents 20 μm.
- Citation: Villarroel M, Ciudin A, Hernández C, Simó R. Neurodegeneration: An early event of diabetic retinopathy. World J Diabetes 2010; 1(2): 57-64
- URL: https://www.wjgnet.com/1948-9358/full/v1/i2/57.htm
- DOI: https://dx.doi.org/10.4239/wjd.v1.i2.57